UCBJF Stock Price, Chart, Stats & News
UCB S.A. (UCBJF) is a dividend-paying stock with a current dividend yield of 0.69% as of Sep 11, 2026. It pays $1.70 per share over the trailing twelve months and distributes annually. Its dividend has grown at a 2.13% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — UCBJF pays out about 16% of earnings.
UCBJF chart
About
UCB S. A. is a prominent biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for individuals affected by neurological and immunological disorders. Its extensive portfolio of marketed products includes Cimzia, indicated for various inflammatory TNF-mediated diseases such as Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, and axial spondyloarthritis (both radiographic and non-radiographic forms).
Related lists
Similar securities
Based on sector and market capitalization
